Drug profile · INN
sincalide
SINCALIDE
sincalide (SINCALIDE) is a cholecystokinin a receptor agonist. Associated with MAIA Biotechnology. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — sincalide
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 4
- Programs
- 0
- Data quality
- 0.89
Quick answer
sincalide (SINCALIDE) is a cholecystokinin a receptor agonist. Associated with MAIA Biotechnology. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Cholecystokinin A receptor agonist
Primary target: Cholecystokinin receptor type A
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
Frequently asked questions
What is sincalide?
sincalide (SINCALIDE) is a cholecystokinin a receptor agonist. Associated with MAIA Biotechnology. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for sincalide?
SINCALIDE is a marketed brand name for sincalide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sincalide?
sincalide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.